Apimeds Pharmaceuticals US, Inc.

APUS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFM14C Feb 27, 2026 INFORMATION STATEMENT
425 Feb 17, 2026 AMENDMENT NO. 2 TO FORM 8-K
8-K/A Feb 17, 2026 AMENDMENT NO. 2 TO FORM 8-K
SCHEDULE 13G Feb 11, 2026
SCHEDULE 13D/A Jan 26, 2026
PREM14C Jan 16, 2026 INFORMATION STATEMENT
8-K Jan 2, 2026 CURRENT REPORT
8-K Dec 10, 2025 CURRENT REPORT
8-K/A Dec 10, 2025 AMENDMENT NO. 1 TO FORM 8-K
425 Dec 2, 2025 CURRENT REPORT
8-K Dec 2, 2025 CURRENT REPORT
4/A Nov 21, 2025 PRIMARY DOCUMENT
8-K Nov 18, 2025 CURRENT REPORT
4 Nov 13, 2025 PRIMARY DOCUMENT
4 Nov 13, 2025 PRIMARY DOCUMENT
4 Nov 13, 2025 PRIMARY DOCUMENT
4 Nov 13, 2025 PRIMARY DOCUMENT
4 Nov 13, 2025 PRIMARY DOCUMENT
10-Q Nov 12, 2025 QUARTERLY REPORT
4 Oct 24, 2025 PRIMARY DOCUMENT
4 Oct 21, 2025 PRIMARY DOCUMENT
4 Oct 17, 2025 PRIMARY DOCUMENT
4 Oct 17, 2025 PRIMARY DOCUMENT
4 Oct 17, 2025 PRIMARY DOCUMENT
4 Oct 17, 2025 PRIMARY DOCUMENT
← Newer Page 2 of 6 · 127 filings Older →